LYPE:XETRA:XETRA-Lyxor MSCI World Health Care TR UCITS ETF - C-EUR EUR (EUR)

ETF | Others |

Last Closing

USD 471.9

Change

0.00 (0.00)%

Market Cap

USD 0.78B

Volume

141.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

ETFs Containing LYPE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.87% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.87% 42% F 47% F
Trailing 12 Months  
Capital Gain 7.96% 47% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.96% 45% F 49% F
Trailing 5 Years  
Capital Gain 52.84% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.84% 76% C+ 75% C
Average Annual (5 Year Horizon)  
Capital Gain 11.29% 70% C- 69% C-
Dividend Return 11.29% 70% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.19% 65% D 73% C
Risk Adjusted Return 122.81% 99% N/A 99% N/A
Market Capitalization 0.78B 73% C 64% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike